Literature DB >> 12642417

Antipsychotic drugs and diabetes.

Roger S McIntyre.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12642417      PMCID: PMC154905     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

Review 1.  Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities.

Authors:  R S McIntyre; S M McCann; S H Kennedy
Journal:  Can J Psychiatry       Date:  2001-04       Impact factor: 4.356

2.  Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database.

Authors:  Frank D Gianfrancesco; Amy L Grogg; Ramy A Mahmoud; Ruey-hua Wang; Henry A Nasrallah
Journal:  J Clin Psychiatry       Date:  2002-10       Impact factor: 4.384

3.  Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials.

Authors:  Eric Wooltorton
Journal:  CMAJ       Date:  2002-11-26       Impact factor: 8.262

Review 4.  Olanzapine-associated diabetes mellitus.

Authors:  Elizabeth A Koller; P Murali Doraiswamy
Journal:  Pharmacotherapy       Date:  2002-07       Impact factor: 4.705

5.  Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study.

Authors:  Carol E Koro; Donald O Fedder; Gilbert J L'Italien; Sheila S Weiss; Laurence S Magder; Julie Kreyenbuhl; Dennis A Revicki; Robert W Buchanan
Journal:  BMJ       Date:  2002-08-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.